Endothelial Dysfunction in Pulmonary Hypertension
Top Cited Papers
Open Access
- 20 January 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (2) , 159-165
- https://doi.org/10.1161/01.cir.0000102381.57477.50
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Circulating endothelial cells in pulmonary hypertensionThrombosis and Haemostasis, 2003
- Nitric Oxide Gas Decreases Endothelin-1 mRNA in Cultured Pulmonary Artery Endothelial CellsNitric Oxide, 2002
- Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT1 receptor antagonist losartanBritish Journal of Pharmacology, 2001
- Three-Dimensional Reconstruction of Pulmonary Arteries in Plexiform Pulmonary Hypertension Using Cell-Specific MarkersThe American Journal of Pathology, 1999
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.Journal of Clinical Investigation, 1996
- Ultrastructural Aspects of Platelet Adhesion on Subendothelial StructuresSeminars in Thrombosis and Hemostasis, 1995
- Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissueJournal Of Hypertension, 1992
- Suppression of polyamine biosynthesis prevents monocrotaline-induced pulmonary edema and arterial medial thickeningToxicology and Applied Pharmacology, 1985
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985